{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/pegcetacoplan.json","peptide":{"slug":"pegcetacoplan","name":"Pegcetacoplan","url":"https://peptidescanner.com/peptides/pegcetacoplan/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":51,"entries":[{"objectId":"story:clinicaltrials-gov-nct02264639-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02264639","domain":"Clinical trials","dateInSource":"2021-01-08","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02264639-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct02264639-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct02264639-pegcetacoplan-v1","contentSha256":"ef2bf2fa02e5652f591db752dc549acb696a2ad3e459e9f97798ab67fe9a0f9b"},{"objectId":"story:clinicaltrials-gov-nct02461771-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02461771","domain":"Clinical trials","dateInSource":"2020-10-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02461771-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct02461771-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct02461771-pegcetacoplan-v1","contentSha256":"02ba7b97ba431e25361b07d9332d51f1ed572ffa5d974b0f202390d924532b6b"},{"objectId":"story:clinicaltrials-gov-nct02503332-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02503332","domain":"Clinical trials","dateInSource":"2020-10-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02503332-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct02503332-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct02503332-pegcetacoplan-v1","contentSha256":"771bcc3a2c1743358ecac7dd98a1fedf8de3409d4993cc3901f64e8757a2a03b"},{"objectId":"story:clinicaltrials-gov-nct02588833-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02588833","domain":"Clinical trials","dateInSource":"2021-01-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02588833-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct02588833-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct02588833-pegcetacoplan-v1","contentSha256":"d6bb6b8299e0c697d7e2412317c70b9d7d1ce95b94990e496c30aa85edf7626e"},{"objectId":"story:clinicaltrials-gov-nct03500549-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT03500549","domain":"Clinical trials","dateInSource":"2022-03-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03500549-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct03500549-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct03500549-pegcetacoplan-v1","contentSha256":"29b8343b4d1e7e4df2897971670328cf11a04d1077f4bc360d86f466878461bb"},{"objectId":"story:clinicaltrials-gov-nct03525613-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT03525613","domain":"Clinical trials","dateInSource":"2023-07-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03525613-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct03525613-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct03525613-pegcetacoplan-v1","contentSha256":"114f47c4a4660178d1aaa8ca2d00c8b6b3ba599e5871170876d0986b2ed4e03f"},{"objectId":"story:clinicaltrials-gov-nct03531255-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT03531255","domain":"Clinical trials","dateInSource":"2026-11-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03531255-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct03531255-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct03531255-pegcetacoplan-v1","contentSha256":"3c66e95d04f0ea69897bf119c61709744508e9785130a12f245931b77a67aa41"},{"objectId":"story:clinicaltrials-gov-nct03593200-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT03593200","domain":"Clinical trials","dateInSource":"2020-12-22","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03593200-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct03593200-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct03593200-pegcetacoplan-v1","contentSha256":"9a41f494327bebdfd763f44a1139bd3fd347940ec6ce064a90a24aee29d01934"},{"objectId":"story:clinicaltrials-gov-nct04572854-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT04572854","domain":"Clinical trials","dateInSource":"2026-04-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04572854-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct04572854-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct04572854-pegcetacoplan-v1","contentSha256":"6d45dfd45ad199e1b66c08fd7b2ace7515bddcf7443fe615c427eef873c9e1eb"},{"objectId":"story:clinicaltrials-gov-nct04901936-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT04901936","domain":"Clinical trials","dateInSource":"2026-06-26","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04901936-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct04901936-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct04901936-pegcetacoplan-v1","contentSha256":"6b6e28405225382208decb6de6516d31ebf9ca181aac6066e3597a802349e090"},{"objectId":"story:clinicaltrials-gov-nct04919629-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT04919629","domain":"Clinical trials","dateInSource":"2026-03-23","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04919629-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct04919629-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct04919629-pegcetacoplan-v1","contentSha256":"37fc67ff576e1fea51e71b4fd9473ddaa4418a9f0cb41cf45d4e39822c8d9bc8"},{"objectId":"story:clinicaltrials-gov-nct05067127-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05067127","domain":"Clinical trials","dateInSource":"2026-01-29","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05067127-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct05067127-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct05067127-pegcetacoplan-v1","contentSha256":"f7d0188ab58d7038e8a24622c2bde3ccaaaa721c03576245700931b56639bf22"},{"objectId":"story:clinicaltrials-gov-nct05096403-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05096403","domain":"Clinical trials","dateInSource":"2025-10-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05096403-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct05096403-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct05096403-pegcetacoplan-v1","contentSha256":"7a12595097c998b9cbb978936e714e86a040a61a26725170d05f5d3e243307b3"},{"objectId":"story:clinicaltrials-gov-nct05148299-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05148299","domain":"Clinical trials","dateInSource":"2025-11-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05148299-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct05148299-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct05148299-pegcetacoplan-v1","contentSha256":"4786d0b7ff97262c689ffc67d5cbb13d31596973b0afc6ed9cbacdfd8660d4d5"},{"objectId":"story:clinicaltrials-gov-nct05776472-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05776472","domain":"Clinical trials","dateInSource":"2026-09-03","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05776472-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct05776472-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct05776472-pegcetacoplan-v1","contentSha256":"1b0941e206d3876c4e29bc45df635b2c2d3441ed48acfe0b52e07af3299d89ef"},{"objectId":"story:clinicaltrials-gov-nct05809531-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05809531","domain":"Clinical trials","dateInSource":"2026-04-02","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05809531-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct05809531-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct05809531-pegcetacoplan-v1","contentSha256":"af46d608b9fe9d7bb7f65d54c868c5b5022febc032e7f4a1cf2459dda77a3192"},{"objectId":"story:clinicaltrials-gov-nct06161584-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT06161584","domain":"Clinical trials","dateInSource":"2026-06-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06161584-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct06161584-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct06161584-pegcetacoplan-v1","contentSha256":"234e0401b474fc56887a3762f64081d05e2b7b3eae46d641ee3e875878f1d63f"},{"objectId":"story:clinicaltrials-gov-nct06722157-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT06722157","domain":"Clinical trials","dateInSource":"2026-11-12","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06722157-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct06722157-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct06722157-pegcetacoplan-v1","contentSha256":"29436ab220c2699743947d460108356aeb49e1f5312ac6109565d663a3fd49e7"},{"objectId":"story:clinicaltrials-gov-nct07160179-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT07160179","domain":"Clinical trials","dateInSource":"2026-07-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07160179-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct07160179-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct07160179-pegcetacoplan-v1","contentSha256":"272eb2008975f39fc3305cdef46f5d2532fa27dc214b0ba9b2a4046e5d15c975"},{"objectId":"story:clinicaltrials-gov-nct07214298-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT07214298","domain":"Clinical trials","dateInSource":"2026-08-19","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07214298-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct07214298-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct07214298-pegcetacoplan-v1","contentSha256":"f2b24f251b69aabdf0789f1b1406e745fa1a26ea81654f646d62f2704f52d8aa"},{"objectId":"story:clinicaltrials-gov-nct07495722-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT07495722","domain":"Clinical trials","dateInSource":"2026-04-29","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07495722-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct07495722-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct07495722-pegcetacoplan-v1","contentSha256":"8ebfd6fbf91ede1d82b3bfca6c6716caa9e824b002d82883b55f216647468f3a"},{"objectId":"story:clinicaltrials-gov-nct07746895-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT07746895","domain":"Clinical trials","dateInSource":"2026-09-09","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07746895-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct07746895-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct07746895-pegcetacoplan-v1","contentSha256":"899a9dabd16e2db9c55bff72aa6150732dd8f75d30290fc98e3ba1f6bd335f84"},{"objectId":"story:clinicaltrials-gov-nct07898774-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT07898774","domain":"Clinical trials","dateInSource":"2026-11-09","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07898774-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#clinicaltrials-gov-nct07898774-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#clinicaltrials-gov-nct07898774-pegcetacoplan-v1","contentSha256":"a0bcda1e897c5095910056c7431d99e9d076e706f3ee46642f8dd20909116c63"},{"objectId":"story:fda-drugs-nda215014:v1","state":"current","stateChangedAt":"2026-11-16","title":"Drugs@FDA application NDA215014","domain":"Regulatory","dateInSource":"2021-05-14","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda215014/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#fda-drugs-nda215014-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#fda-drugs-nda215014-v1","contentSha256":"08e86e59cc9a743a4b68b97f76ff06b515bef5ddad2d88bdfaf29015b3c632f6"},{"objectId":"story:fda-drugs-nda217171:v1","state":"current","stateChangedAt":"2026-11-16","title":"Drugs@FDA application NDA217171","domain":"Regulatory","dateInSource":"2023-02-17","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda217171/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#fda-drugs-nda217171-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#fda-drugs-nda217171-v1","contentSha256":"6b08767e8836cbcfe116cdfe6a800ea76f09e09c7bc06e11307c2db14c5fb391"},{"objectId":"story:federal-register-2023-26255:v1","state":"current","stateChangedAt":"2026-11-16","title":"Federal Register notice 2023-26255","domain":"Regulatory","dateInSource":"2023-11-29","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/federal-register-2023-26255/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#federal-register-2023-26255-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#federal-register-2023-26255-v1","contentSha256":"316aa90283aceca2cb0c1a1d3339ac1d24369e3d3b9d7c6ca5e94971c1778d3d"},{"objectId":"story:pubmed-pmid-36965105-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data.","domain":"Literature metadata","dateInSource":"2026-01-27","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36965105-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-36965105-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-36965105-pegcetacoplan-v1","contentSha256":"a30da1fa0352f0eb9175900740a3764cf81447b638c656008dc270db953d518a"},{"objectId":"story:pubmed-pmid-37195551-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.","domain":"Literature metadata","dateInSource":"2023-07-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37195551-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-37195551-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-37195551-pegcetacoplan-v1","contentSha256":"99eeebe072b25a5bc2c17a501070fe372346a637058a5643a9e5664a4c2f1f16"},{"objectId":"story:pubmed-pmid-37259853-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"WITHDRAWN: Pegcetacoplan in the treatment of geographic atrophy.","domain":"Literature metadata","dateInSource":"2023-06-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37259853-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-37259853-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-37259853-pegcetacoplan-v1","contentSha256":"2868e3b71f87b051d62bd62d7ab01978cebd9c53d5f49d56e8a89cbbbc2252c8"},{"objectId":"story:pubmed-pmid-37815317-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Treatment of geographic atrophy: an update on data related to pegcetacoplan.","domain":"Literature metadata","dateInSource":"2025-07-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37815317-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-37815317-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-37815317-pegcetacoplan-v1","contentSha256":"8497f8c72265188badc2885fc9b4b61969ffb73034c03ab6ee922931a5ee2829"},{"objectId":"story:pubmed-pmid-38098608-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Advancements in the treatment of geographic atrophy: focus on pegcetacoplan in age-related macular degeneration.","domain":"Literature metadata","dateInSource":"2023-12-16","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38098608-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-38098608-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-38098608-pegcetacoplan-v1","contentSha256":"3329fd5733877000f69b23e63126ec90501253837b2c49e0f5140de1602cc216"},{"objectId":"story:pubmed-pmid-38453703-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan.","domain":"Literature metadata","dateInSource":"2024-09-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38453703-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-38453703-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-38453703-pegcetacoplan-v1","contentSha256":"624767f23d28258b7e9a185d8ff992e2e63d277c73542272dd08a80f17714eed"},{"objectId":"story:pubmed-pmid-38593241-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria.","domain":"Literature metadata","dateInSource":"2024-11-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38593241-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-38593241-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-38593241-pegcetacoplan-v1","contentSha256":"8e599662174d711af3e171f5d9794830dec386f90ad6891567b9182cd5734b0e"},{"objectId":"story:pubmed-pmid-38722644-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan Treatment and Consensus Features of Geographic Atrophy Over 24 Months.","domain":"Literature metadata","dateInSource":"2026-08-27","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38722644-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-38722644-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-38722644-pegcetacoplan-v1","contentSha256":"34db5c8474af89713894e83c9d06a211e7ac533b7a21f1b0c0f57d9106103bfd"},{"objectId":"story:pubmed-pmid-38727860-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan.","domain":"Literature metadata","dateInSource":"2025-01-27","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38727860-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-38727860-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-38727860-pegcetacoplan-v1","contentSha256":"a0e58b7062f4f9f324608e395c77371215b0910e77bd35a556bf5c4f025063ac"},{"objectId":"story:pubmed-pmid-39201278-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function.","domain":"Literature metadata","dateInSource":"2024-09-03","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39201278-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-39201278-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-39201278-pegcetacoplan-v1","contentSha256":"909d75500dca0caac9c0a7c183dd3434c3a035a593b52a28e37bec5d3cc9e0e1"},{"objectId":"story:pubmed-pmid-39497616-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or sham.","domain":"Literature metadata","dateInSource":"2026-09-24","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39497616-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-39497616-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-39497616-pegcetacoplan-v1","contentSha256":"c10b1b3ee4dd1e0a2379a2ef668dedf2762709daa25e3b6cc346080183006d13"},{"objectId":"story:pubmed-pmid-39656072-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria.","domain":"Literature metadata","dateInSource":"2026-09-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39656072-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-39656072-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-39656072-pegcetacoplan-v1","contentSha256":"fadda1304083f64b6a002bd8651256a5a0d85702fbd9d3c6006bf69ee92a1f46"},{"objectId":"story:pubmed-pmid-40280279-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE.","domain":"Literature metadata","dateInSource":"2025-07-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40280279-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-40280279-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-40280279-pegcetacoplan-v1","contentSha256":"07b405917e0514fc2af1eb62914b9045dd1ef9f7058e181997b0e68ccd5d2136"},{"objectId":"story:pubmed-pmid-40833323-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Dynamics of the EZ/RPE Loss Ratio on OCT Over Time During Geographic Atrophy Progression and Treatment With Pegcetacoplan.","domain":"Literature metadata","dateInSource":"2026-08-23","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40833323-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-40833323-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-40833323-pegcetacoplan-v1","contentSha256":"2ce898c4688e46882370171d3f87c94577bec205e98f897ac6318e6c3b73336c"},{"objectId":"story:pubmed-pmid-41337715-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.","domain":"Literature metadata","dateInSource":"2026-03-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41337715-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-41337715-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-41337715-pegcetacoplan-v1","contentSha256":"c8759b5f608f9862f2143bb54d0ac0dcdaba7382ca80fbe117225c39750b4062"},{"objectId":"story:pubmed-pmid-42022788-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Direct Switch From Iptacopan to Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria.","domain":"Literature metadata","dateInSource":"2026-08-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42022788-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42022788-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42022788-pegcetacoplan-v1","contentSha256":"10bf2fc928d8e22b3ffd9d1bec974b12f6c00c0d47397e1a091710bbc1283528"},{"objectId":"story:pubmed-pmid-42061561-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan prophylaxis for recurrent C3 glomerulopathy with multifactorial genetic background.","domain":"Literature metadata","dateInSource":"2026-07-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42061561-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42061561-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42061561-pegcetacoplan-v1","contentSha256":"390fef655f1d953ca52824d4663484af84a28a56c38bd4e2207c937c9e579553"},{"objectId":"story:pubmed-pmid-42133432-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis.","domain":"Literature metadata","dateInSource":"2026-08-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42133432-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42133432-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42133432-pegcetacoplan-v1","contentSha256":"4b22cab404d87c50942eaadcad54f05d34bff07d09bc3032bd089f00ea7a2b8c"},{"objectId":"story:pubmed-pmid-42138781-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.","domain":"Literature metadata","dateInSource":"2026-08-26","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42138781-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42138781-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42138781-pegcetacoplan-v1","contentSha256":"98b77fc41c08a4e2d6c9765bdb48ef850d1662dd63cbd67bd0a4b28b826afd2e"},{"objectId":"story:pubmed-pmid-42800616-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Podocyte and tubular vacuolization in patients receiving pegcetacoplan.","domain":"Literature metadata","dateInSource":"2026-10-16","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42800616-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42800616-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42800616-pegcetacoplan-v1","contentSha256":"05a5345b678a7e35849bb7de626ef6c0edde0e554ddae12bca16ec7eae7f43c5"},{"objectId":"story:pubmed-pmid-42898424-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Distinct Pharmacodynamic Complement Biomarker Signatures Define Iptacopan and Pegcetacoplan Treatment in C3 Glomerulopathy.","domain":"Literature metadata","dateInSource":"2026-10-22","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42898424-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42898424-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42898424-pegcetacoplan-v1","contentSha256":"30ad962dd0a3209d532a28f4afc6f2041e81916bbe1b94aabee6cec378457f23"},{"objectId":"story:pubmed-pmid-42930807-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Temporal, Phenotypic, and Treatment-Context Heterogeneity in Retinal Vasculitis Reporting with Pegcetacoplan: A United States Pharmacovigilance Study.","domain":"Literature metadata","dateInSource":"2026-10-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42930807-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42930807-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42930807-pegcetacoplan-v1","contentSha256":"e89488e58df939eae451d4a893f000ef1efff4421c986a6876941a7bfefd5de8"},{"objectId":"story:pubmed-pmid-42972953-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mixed Intravascular and Extravascular Hemolysis Despite Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case of Switching to Pegcetacoplan.","domain":"Literature metadata","dateInSource":"2026-11-03","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42972953-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42972953-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42972953-pegcetacoplan-v1","contentSha256":"25ae10a7d2c00af9f3ee526e572b1fa31adb0e95f060c0fd5427c67f5e03f8a2"},{"objectId":"story:pubmed-pmid-42998772-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan for geographic atrophy: Bridging the \"clinical relevance gap\" through precision medicine.","domain":"Literature metadata","dateInSource":"2026-11-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42998772-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-42998772-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-42998772-pegcetacoplan-v1","contentSha256":"057551f8efc41838468ca047efade7d65639a22d64b8a0470e732f664ee95d4f"},{"objectId":"story:pubmed-pmid-43024395-pegcetacoplan:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pegcetacoplan in C3 Glomerulopathy and Primary Immune-Complex MPGN.","domain":"Literature metadata","dateInSource":"2026-11-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-43024395-pegcetacoplan/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.json#pubmed-pmid-43024395-pegcetacoplan-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pegcetacoplan.md#pubmed-pmid-43024395-pegcetacoplan-v1","contentSha256":"a97731afc946cd67481f7cba3ebc622be4c42746f56c8b7f5f2ccd9a689dcc74"}]}
